Prospective study of 5-day challenge with penicillins in children.
history of medicine
pharmacology
Journal
BMJ paediatrics open
ISSN: 2399-9772
Titre abrégé: BMJ Paediatr Open
Pays: England
ID NLM: 101715309
Informations de publication
Date de publication:
2020
2020
Historique:
received:
16
05
2020
revised:
02
07
2020
accepted:
06
07
2020
entrez:
21
8
2020
pubmed:
21
8
2020
medline:
21
8
2020
Statut:
epublish
Résumé
To examine if a 5-day challenge with penicillin improves the diagnostic sensitivity compared with a single full dose in children with mild skin reactions. Subjects referred with suspected allergy to penicillin were consecutively included. Irrespectively of the morphology of the index reaction and the result of specific IgE, all subjects underwent a two-step titrated drug provocation test (DPT) with the culprit drug followed by a 5-day challenge at home. Children and adolescents aged 0-18 years referred to allergic workup for penicillin hypersensitivity at two paediatric Danish centres. Only subjects with non-severe skin reactions were included. A total of 305 subjects were included and 22 (7%) of the DPTs were positive. Three subjects reacted within 1 hour of the first full dose and nine reacted 1-8 hours after the first full dose. Additional 10 positive reactions were observed during the prolonged provocation. Seven subjects reacted after the second full dose and three reacted after 3-6 days. Only mild skin rashes were observed. Eighteen subjects had a specific IgE to a penicillin >0.1 kU/L. Only one of these had a positive DPT. In children, a DPT with penicillins should include at least two full doses. In children with mild hypersensitivity reactions it may be safe to perform DPTs despite a low specific IgE. NCT04331522.
Identifiants
pubmed: 32818157
doi: 10.1136/bmjpo-2020-000734
pii: bmjpo-2020-000734
pmc: PMC7406022
doi:
Banques de données
ClinicalTrials.gov
['NCT04331522']
Types de publication
Journal Article
Langues
eng
Pagination
e000734Informations de copyright
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Allergy. 2003 Oct;58(10):961-72
pubmed: 14510712
Allergy. 2009 Feb;64(2):229-33
pubmed: 19178402
N Engl J Med. 2019 Dec 12;381(24):2338-2351
pubmed: 31826341
Allergy. 2019 Jun;74(6):1052-1062
pubmed: 30637768
Arch Intern Med. 2002 Apr 8;162(7):822-6
pubmed: 11926858
Allergy. 2009 Feb;64(2):242-8
pubmed: 19178404
Ann Allergy Asthma Immunol. 2016 Apr;116(4):329-33
pubmed: 26922211
Allergy. 2016 Feb;71(2):149-61
pubmed: 26416157
Pediatr Allergy Immunol. 2013 Mar;24(2):160-7
pubmed: 23373964
J Allergy Clin Immunol Pract. 2019 Sep - Oct;7(7):2163-2170
pubmed: 31170542
J Allergy Clin Immunol Pract. 2017 May - Jun;5(3):669-675
pubmed: 28483317
Allergy. 2020 Jun;75(6):1300-1315
pubmed: 31749148
J Allergy Clin Immunol Pract. 2018 Sep - Oct;6(5):1673-1680
pubmed: 29425903
Allergy Asthma Proc. 2019 Jan 1;40(1):57-61
pubmed: 30582497
Clin Chim Acta. 2020 May;504:119-124
pubmed: 32035852
Allergy. 2019 Dec;74(12):2482-2484
pubmed: 31087349
Allergy. 2004 Nov;59(11):1153-60
pubmed: 15461594
Clin Exp Allergy. 2008 Jan;38(1):191-8
pubmed: 18028465
Paediatr Child Health. 2020 Feb;25(1):62-63
pubmed: 32042244
J Allergy Clin Immunol Pract. 2017 Sep - Oct;5(5):1394-1401
pubmed: 28454683
Allergy. 2009 Feb;64(2):183-93
pubmed: 19133923
J Allergy Clin Immunol Pract. 2018 Jul - Aug;6(4):1321-1326
pubmed: 29175371
J Allergy Clin Immunol Pract. 2015 May-Jun;3(3):375-80.e1
pubmed: 25609343